 | • レポートコード：MRC2303A099 • 出版社/出版日：Persistence Market Research / 2022年12月26日 • レポート形態：英文、PDF、250ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥735,000 (USD4,900) | ▷ お問い合わせ |
| Site Licence | ￥1,140,000 (USD7,600) | ▷ お問い合わせ |
| Enterprisewide | ￥1,590,000 (USD10,600) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Persistence Market Research社発行の当調査レポートでは、世界の合成生物市場の現状について調査・分析し、エグゼクティブサマリー、市場概要、市場リスク・動向分析、市場背景、主要成功要因、市場需要分析、市場価値分析、市場構造分析、競争分析、仮定、調査手法などの構成でまとめております。セグメント分析では、用途別（医療、非医療）、製品タイプ別（オリゴヌクレオチド/オリゴプール＆合成DNA、酵素、クローニング技術キット、異種核酸、シャシー生物）、技術別（NGS、PCR、ゲノム編集、その他）、エンドユーザー別（バイオテクノロジー＆製薬企業、学術＆政府研究機関、その他）、地域別（北米、中南米、ヨーロッパ、アジア太平洋、中東/アフリカ）の情報が含まれています。なお、当市場の主要企業には、Bota Biosciences、Codexis, Inc.、Creative Biogene、Creative Enzymes、EnBiotix、Eurofins Scientific、Illumina、Merck (Sigma Aldrich)、New England Biolabs、Novozymesなどが含まれています。 ・エグゼクティブサマリー ・市場概要 ・市場リスク・動向分析 ・市場背景 ・主要成功要因 ・市場需要分析 ・市場価値分析 ・世界の合成生物市場規模：用途別 - 医療における市場規模 - 非医療における市場規模 ・世界の合成生物市場規模：製品タイプ別 - オリゴヌクレオチド/オリゴプール＆合成DNAの市場規模 - 酵素の市場規模 - クローニング技術キットの市場規模 - 異種核酸の市場規模 - シャシー生物の市場規模 ・世界の合成生物市場規模：技術別 - NGS技術の市場規模 - PCR技術の市場規模 - ゲノム編集技術の市場規模 - その他技術の市場規模 ・世界の合成生物市場規模：エンドユーザー別 - バイオテクノロジー＆製薬企業における市場規模 - 学術＆政府研究機関における市場規模 - その他エンドユーザーにおける市場規模 ・世界の合成生物市場規模：地域別 - 北米の合成生物市場規模 - 中南米の合成生物市場規模 - ヨーロッパの合成生物市場規模 - アジア太平洋の合成生物市場規模 - 中東/アフリカの合成生物市場規模 ・市場構造分析 ・競争分析 ・仮定 ・調査手法 |
Synthetic Biology Market: Global Industry Analysis 2017-2021 & Opportunity Assessment 2022-2032
A recent market study published by Persistence Market Research on the Synthetic Biology market offers global industry analysis for 2017-2021 & opportunity assessment for 2022-2032. The study offers a comprehensive assessment of the most important market dynamics. After conducting a thorough research on the historical, as well as current growth parameters, the growth prospects of the market are obtained with maximum precision.
Market Segmentation
The Synthetic Biology market is segmented in detail to cover every aspect of the market and present complete market intelligence to readers.
By Application
Healthcare
Non-Healthcare
By Product Type
Oligonucleotide/Oligo pools and Synthetic DNA
Enzymes
Cloning Technologies Kits
Xeno-nucleic Acids
Chassis Organism
By Technology
NGS
PCR
Genome Editing
Bioprocessing Technology
Other Technologies
By End-use
Biotechnology & Pharmaceutical Companies
Academic & Government Research Institutes
Other End-uses
By Region
North America
Europe
Asia Pacific
Middle East and Africa
Latin America
Report Chapters
Chapter 01 – Executive Summary
The executive summary of the Synthetic Biology market includes the global market analysis, proprietary wheel of fortune, demand-side and supply-side trends, opportunity assessment, and recommendations on the Synthetic Biology market.
Chapter 02 – Market Overview
Readers can find the detailed segmentation and definition of the Synthetic Biology market in this chapter, which will help them understand basic information about the Synthetic Biology market. This section also highlights the inclusions and exclusions, which help the reader to understand the scope of the Synthetic Biology market report.
Chapter 03 – Market Background
The associated industry assessment of the Synthetic Biology market is carried out in this section. In addition, this chapter explains key macroeconomic factors that are expected to influence the growth of the Synthetic Biology market over the forecast period. Along with macroeconomic factors, this section also highlights the opportunity analysis for the market. It offers provides key market dynamics of the Synthetic Biology market, which include drivers, restraints, and opportunities. Moreover, it will help readers understand key trends followed by leading manufacturers in the Synthetic Biology market.
Chapter 04 – Synthetic Biology Market Analysis 2017-2021 and Forecast, 2022-2032
This section provides detailed analysis of the historical Synthetic Biology market Value, along with an opportunity analysis of the future. Readers can also find the incremental opportunity for the current year (2021–2022) and an absolute opportunity for the forecast period (2022–2032).
Chapter 05 – Synthetic Biology Market Analysis 2017-2021 and Forecast 2022-2032, by Application
Based on Application, the Synthetic Biology market is segmented into (Healthcare and Non-Healthcare). In this chapter, readers can find market attractiveness analysis, based on application.
Chapter 06 – Synthetic Biology Market Analysis 2017-2021 and Forecast 2022-2032, by Product Type
Based on Product Type, the Synthetic Biology market is segmented into Oligonucleotide/Oligo pools and Synthetic DNA, Enzymes, Cloning Technologies Kits, Xeno-nucleic Acids, Chassis Organism. In this chapter, readers can find market attractiveness analysis, based on Product type.
Chapter 07 – Synthetic Biology Market Analysis 2017-2021 and Forecast 2022-2032, by End-use
Based on End-use, the Synthetic Biology market is segmented into Biotechnology & Pharmaceutical Companies, Academic & Government Research Institutes, Other End-uses. In this chapter, readers can find market attractiveness analysis, based on End-use.
Chapter 08 – Synthetic Biology Market Analysis 2017-2021 and Forecast 2022-2032, by Technology
Based on technology, the Synthetic Biology market is segmented into NGS, PCR, Genome Editing, Bioprocessing Technology, Other Technologies. In this chapter, readers can find market attractiveness analysis, based on technology.
Chapter 09 – Synthetic Biology Market Analysis 2017-2021 and Opportunity Assessment 2022-2032 by Region
This chapter explains how the Synthetic Biology market will grow across various geographic regions, such as North America, Latin America, Europe, Asia Pacific and the Middle East and Africa (MEA).
Chapter 10 – North America Synthetic Biology Market Analysis 2017-2021 & Forecast 2022-2032
This chapter includes a detailed analysis of the growth of the Synthetic Biology market in the North America region, along with a country-wise assessment that includes the U.S. and Canada. Readers can also find regional trends, opportunities, and market growth based on Application, Product type, Technology, End-use and countries in the North America region.
Chapter 11 – Latin America Synthetic Biology Market Analysis 2017-2021 & Forecast 2022-2032
Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the Synthetic Biology market in the Latin America region. This chapter also includes growth prospects of the Synthetic Biology market in leading LATAM countries such as Brazil and Mexico.
Chapter 12 – Europe Synthetic Biology Market Analysis 2017-2021 & Forecast 2022-2032
Important growth prospects of the Synthetic Biology market based on its product type, price, and sales channel in several countries such as Germany, U.K., France, Italy, BENELUX, Nordics, Russia, and Rest of Europe are included in this chapter.
Chapter 13 – Asia Pacific Synthetic Biology Market Analysis 2017-2021 & Forecast 2022-2032
This chapter includes a detailed analysis of the growth of the Synthetic Biology market in the South Asia region, along with a country-wise assessment that includes, China, Japan and South Korea. Readers can also find regional trends, restraints, and market growth of countries in the Asia Pacific region.
Chapter 14 – Middle East and Africa Synthetic Biology Market Analysis 2017-2021 & Forecast 2022-2032
This chapter offers insights into how the Synthetic Biology market is expected to grow in major countries in the MEA region such as GCC Countries, South Africa, and the Turkey, during the forecast period 2022-2032.
Chapter 15 – Key Countries Synthetic Biology Market Analysis
This chapter offers insights into how the Synthetic Biology market is expected to grow in key countries in the such as U.S., Canada, Brazil, Mexico, Germany, U.K., France, Italy, BENELUX, Nordic, Rest of Europe, China, Japan, South Korea, GCC, South Africa, and Turkey during the forecast period 2022-2032.
Chapter 16 – Market Structure Analysis
In this chapter, readers can find detailed information about tier analysis and market concentration of the key players in the Synthetic Biology market along with their market presence analysis by region and product portfolio.
Chapter 17 – Competition Deep-Dive Analysis
In this chapter, readers can find a comprehensive list of manufacturers/ players in the Synthetic Biology market, along with detailed information about each company, which includes company overview, revenue shares, strategic overview, and recent company developments. Some of the market players featured in the report are Bota Biosciences, Codexis, Inc., Creative Biogene, Creative Enzymes, EnBiotix, Inc., Eurofins Scientific, Illumina, Merck, New England Biolabs, Novozymes, Pareto Biotechnologies, Inc., Scarab Genomics, Synthego, Synthetic Genomics, and Thermo Fisher adopt several strategies to enhance their revenue and market standings.
Chapter 18 – Assumptions and Acronyms
This chapter includes a list of acronyms and assumptions that provide a base to the information and statistics included in the Synthetic Biology market report.
Chapter 19 – Research Methodology
This chapter helps readers understand the research methodology followed to obtain various conclusions, as well as important qualitative and quantitative information, on the Synthetic Biology market.
1. Executive Summary
1.1. Global Market Outlook
1.2. Summary of Statistics
1.3. Key Market Characteristics & Attributes
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage
2.2. Market Definition
3. Market Risks and Trends Assessment
3.1. Risk Assessment
3.1.1. COVID-19 Crisis and Impact on Synthetic Biology
3.1.2. COVID-19 Impact Benchmark with Previous Crisis
3.1.3. Impact on Market Value (US$ Mn)
3.1.4. Assessment by Key Countries
3.1.5. Assessment by Key Market Segments
3.1.6. Action Points and Recommendation for Suppliers
3.2. Key Trends Impacting the Market
3.3. Formulation and Product Development Trends
4. Market Background
4.1. Synthetic Biology Market, by Key Countries
4.2. Synthetic Biology Market Opportunity Assessment (US$ Mn)
4.2.1. Total Available Market
4.2.2. Serviceable Addressable Market
4.2.3. Serviceable Obtainable Market
4.3. Market Scenario Forecast
4.3.1. Demand in optimistic Scenario
4.3.2. Demand in Likely Scenario
4.3.3. Demand in Conservative Scenario
4.4. Investment Feasibility Analysis
4.4.1. Investment in Established Markets
4.4.1.1. In Short Term
4.4.1.2. In Long Term
4.4.2. Investment in Emerging Markets
4.4.2.1. In Short Term
4.4.2.2. In Long Term
4.5. Forecast Factors – Relevance & Impact
4.5.1. Top Companies Historical Growth
4.5.2. Growth in Automation, By Country
4.5.3. Synthetic Biology Adoption Rate, By Country
4.6. Market Dynamics
4.6.1. Market Driving Factors and Impact Assessment
4.6.2. Prominent Market Challenges and Impact Assessment
4.6.3. Synthetic Biology Market Opportunities
4.6.4. Prominent Trends in the Global Market & Their Impact Assessment
5. Key Success Factors
5.1. Manufacturers’ Focus on Low Penetration High Growth Markets
5.2. Banking on with Segments High Incremental Opportunity
5.3. Peer Benchmarking
6. Global Synthetic Biology Market Demand Analysis 2017-2021 and Forecast, 2022-2032
6.1. Historical Market Analysis, 2017-2021
6.2. Current and Future Market Projections, 2022-2032
6.3. Y-o-Y Growth Trend Analysis
7. Global Synthetic Biology Market Value Analysis 2017-2021 and Forecast, 2022-2032
7.1. Historical Market Value (US$ Mn) Analysis, 2017-2021
7.2. Current and Future Market Value (US$ Mn) Projections, 2022-2032
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis
8. Global Synthetic Biology Market Analysis 2017-2021 and Forecast 2022-2032, By Application
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn) Analysis By Application, 2017-2021
8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Application, 2022-2032
8.3.1. Healthcare
8.3.1.1. Clinical
8.3.1.2. Non-Clinical /Research
8.3.2. Non-Healthcare
8.3.2.1. Biotech Crops
8.3.2.2. Speciality Chemicals
8.3.2.3. Bio-Fuels
8.4. Market Attractiveness Analysis By Application
9. Global Synthetic Biology Market Analysis 2017-2021 and Forecast 2022-2032, By Product Type
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) Analysis By Product Type, 2017-2021
9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product Type, 2022-2032
9.3.1. Oligonucleotide/Oligo pools and Synthetic DNA
9.3.2. Enzymes
9.3.3. Cloning Technologies Kits
9.3.4. Xeno-nucleic Acids
9.3.5. Chassis Organism
9.4. Market Attractiveness Analysis By Product Type
10. Global Synthetic Biology Market Analysis 2017-2021 and Forecast 2022-2032, By Technology
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) Analysis By Technology, 2017-2021
10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Technology, 2022-2032
10.3.1. NGS
10.3.2. PCR
10.3.3. Genome Editing
10.3.4. Other Technologies
10.4. Market Attractiveness Analysis By Technology
11. Global Synthetic Biology Market Analysis 2017-2021 and Forecast 2022-2032, By End-use
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Mn) Analysis By End-use, 2017-2021
11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End-use, 2022-2032
11.3.1. Biotechnology & Pharmaceutical Companies
11.3.2. Academic & Government Research Institutes
11.3.3. Other End-uses
11.4. Market Attractiveness Analysis By End-use
12. Global Synthetic Biology Market Analysis 2017-2021 and Forecast 2022-2032, By Region
12.1. Introduction
12.2. Historical Market Size (US$ Mn) Analysis By Region, 2017-2021
12.3. Current Market Size (US$ Mn) & Analysis and Forecast By Region, 2022-2032
12.3.1. North America
12.3.2. Latin America
12.3.3. Europe
12.3.4. Asia Pacific
12.3.5. Middle East and Africa (MEA)
12.4. Market Attractiveness Analysis By Region
13. North America Synthetic Biology Market Analysis 2017-2021 and Forecast 2022-2032
13.1. Introduction
13.2. Pricing Analysis
13.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
13.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
13.4.1. By Country
13.4.1.1. U.S.
13.4.1.2. Canada
13.4.1.3. Rest of North America
13.4.2. By Application
13.4.3. By Product Type
13.4.4. By Technology
13.4.5. By End-use
13.5. Market Attractiveness Analysis
13.5.1. By Country
13.5.2. By Application
13.5.3. By Product Type
13.5.4. By Technology
13.5.5. By End-use
14. Latin America Synthetic Biology Market Analysis 2017-2021 and Forecast 2022-2032
14.1. Introduction
14.2. Pricing Analysis
14.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
14.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
14.4.1. By Country
14.4.1.1. Brazil
14.4.1.2. Mexico
14.4.1.3. Rest of Latin America
14.4.2. By Application
14.4.3. By Product Type
14.4.4. By Technology
14.4.5. By End-use
14.5. Market Attractiveness Analysis
14.5.1. By Country
14.5.2. By Application
14.5.3. By Product Type
14.5.4. By Technology
14.5.5. By End-use
15. Europe Synthetic Biology Market Analysis 2017-2021 and Forecast 2022-2032
15.1. Introduction
15.2. Pricing Analysis
15.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
15.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
15.4.1. By Country
15.4.1.1. Germany
15.4.1.2. France
15.4.1.3. U.K.
15.4.1.4. Italy
15.4.1.5. Benelux
15.4.1.6. Nordic Countries
15.4.1.7. Rest of Europe
15.4.2. By Application
15.4.3. By Product Type
15.4.4. By Technology
15.4.5. By End-use
15.5. Market Attractiveness Analysis
15.5.1. By Country
15.5.2. By Application
15.5.3. By Product Type
15.5.4. By Technology
15.5.5. By End-use
16. Asia Pacific Synthetic Biology Market Analysis 2017-2021 and Forecast 2022-2032
16.1. Introduction
16.2. Pricing Analysis
16.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
16.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
16.4.1. By Country
16.4.1.1. China
16.4.1.2. Japan
16.4.1.3. South Korea
16.4.1.4. Rest of Asia Pacific
16.4.2. By Application
16.4.3. By Product Type
16.4.4. By Technology
16.4.5. By End-use
16.5. Market Attractiveness Analysis
16.5.1. By Country
16.5.2. By Application
16.5.3. By Product Type
16.5.4. By Technology
16.5.5. By End-use
17. Middle East and Africa Synthetic Biology Market Analysis 2017-2021 and Forecast 2022-2032
17.1. Introduction
17.2. Pricing Analysis
17.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
17.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
17.4.1. By Country
17.4.1.1. GCC Countries
17.4.1.2. South Africa
17.4.1.3. Turkey
17.4.1.4. Rest of Middle East and Africa
17.4.2. By Application
17.4.3. By Product Type
17.4.4. By Technology
17.4.5. By End-use
17.5. Market Attractiveness Analysis
17.5.1. By Country
17.5.2. By Application
17.5.3. By Product Type
17.5.4. By Technology
17.5.5. By End-use
18. Key Countries Synthetic Biology Market Analysis 2017-2021 and Forecast 2022-2032
18.1. Introduction
18.1.1. Market Value Proportion Analysis, By Key Countries
18.1.2. Global Vs. Country Growth Comparison
18.2. US Synthetic Biology Market Analysis
18.2.1. Value Proportion Analysis by Market Taxonomy
18.2.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032
18.2.2.1. By Application
18.2.2.2. By Product Type
18.2.2.3. By Technology
18.2.2.4. By End-use
18.3. Canada Synthetic Biology Market Analysis
18.3.1. Value Proportion Analysis by Market Taxonomy
18.3.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032
18.3.2.1. By Application
18.3.2.2. By Product Type
18.3.2.3. By Technology
18.3.2.4. By End-use
18.4. Mexico Synthetic Biology Market Analysis
18.4.1. Value Proportion Analysis by Market Taxonomy
18.4.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032
18.4.2.1. By Application
18.4.2.2. By Product Type
18.4.2.3. By Technology
18.4.2.4. By End-use
18.5. Brazil Synthetic Biology Market Analysis
18.5.1. Value Proportion Analysis by Market Taxonomy
18.5.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032
18.5.2.1. By Application
18.5.2.2. By Product Type
18.5.2.3. By Technology
18.5.2.4. By End-use
18.6. Germany Synthetic Biology Market Analysis
18.6.1. Value Proportion Analysis by Market Taxonomy
18.6.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032
18.6.2.1. By Application
18.6.2.2. By Product Type
18.6.2.3. By Technology
18.6.2.4. By End-use
18.7. France Synthetic Biology Market Analysis
18.7.1. Value Proportion Analysis by Market Taxonomy
18.7.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032
18.7.2.1. By Application
18.7.2.2. By Product Type
18.7.2.3. By Technology
18.7.2.4. By End-use
18.8. Italy Synthetic Biology Market Analysis
18.8.1. Value Proportion Analysis by Market Taxonomy
18.8.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032
18.8.2.1. By Application
18.8.2.2. By Product Type
18.8.2.3. By Technology
18.8.2.4. By End-use
18.9. BENELUX Synthetic Biology Market Analysis
18.9.1. Value Proportion Analysis by Market Taxonomy
18.9.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032
18.9.2.1. By Application
18.9.2.2. By Product Type
18.9.2.3. By Technology
18.9.2.4. By End-use
18.10. UK Synthetic Biology Market Analysis
18.10.1. Value Proportion Analysis by Market Taxonomy
18.10.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032
18.10.2.1. By Application
18.10.2.2. By Product Type
18.10.2.3. By Technology
18.10.2.4. By End-use
18.11. Nordic Countries Synthetic Biology Market Analysis
18.11.1. Value Proportion Analysis by Market Taxonomy
18.11.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032
18.11.2.1. By Application
18.11.2.2. By Product Type
18.11.2.3. By Technology
18.11.2.4. By End-use
18.12. China Synthetic Biology Market Analysis
18.12.1. Value Proportion Analysis by Market Taxonomy
18.12.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032
18.12.2.1. By Application
18.12.2.2. By Product Type
18.12.2.3. By Technology
18.12.2.4. By End-use
18.13. Japan Synthetic Biology Market Analysis
18.13.1. Value Proportion Analysis by Market Taxonomy
18.13.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032
18.13.2.1. By Application
18.13.2.2. By Product Type
18.13.2.3. By Technology
18.13.2.4. By End-use
18.14. South Korea Synthetic Biology Market Analysis
18.14.1. Value Proportion Analysis by Market Taxonomy
18.14.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032
18.14.2.1. By Application
18.14.2.2. By Product Type
18.14.2.3. By Technology
18.14.2.4. By End-use
18.15. GCC Countries Synthetic Biology Market Analysis
18.15.1. Value Proportion Analysis by Market Taxonomy
18.15.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032
18.15.2.1. By Application
18.15.2.2. By Product Type
18.15.2.3. By Technology
18.15.2.4. By End-use
18.16. South Africa Synthetic Biology Market Analysis
18.16.1. Value Proportion Analysis by Market Taxonomy
18.16.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032
18.16.2.1. By Application
18.16.2.2. By Product Type
18.16.2.3. By Technology
18.16.2.4. By End-use
18.17. Turkey Synthetic Biology Market Analysis
18.17.1. Value Proportion Analysis by Market Taxonomy
18.17.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032
18.17.2.1. By Application
18.17.2.2. By Product Type
18.17.2.3. By Technology
18.17.2.4. By End-use
18.17.3. Competition Landscape and Player Concentration in the Country
19. Market Structure Analysis
19.1. Market Analysis by Tier of Companies
19.2. Market Concentration
19.3. Market Share Analysis of Top Players
19.4. Market Presence Analysis
19.4.1. By Regional footprint of Players
19.4.2. Product footprint by Players
20. Competition Analysis
20.1. Competition Dashboard
20.2. Competition Benchmarking
20.3. Competition Deep Dive
20.3.1. Bota Biosciences
20.3.1.1. Overview
20.3.1.2. Product Portfolio
20.3.1.3. Sales Footprint
20.3.1.4. Strategy Overview
20.3.2. Codexis, Inc.
20.3.2.1. Overview
20.3.2.2. Product Portfolio
20.3.2.3. Sales Footprint
20.3.2.4. Strategy Overview
20.3.3. Creative Biogene
20.3.3.1. Overview
20.3.3.2. Product Portfolio
20.3.3.3. Sales Footprint
20.3.3.4. Strategy Overview
20.3.4. Creative Enzymes
20.3.4.1. Overview
20.3.4.2. Product Portfolio
20.3.4.3. Sales Footprint
20.3.4.4. Strategy Overview
20.3.5. EnBiotix
20.3.5.1. Overview
20.3.5.2. Product Portfolio
20.3.5.3. Sales Footprint
20.3.5.4. Strategy Overview
20.3.6. Eurofins Scientific
20.3.6.1. Overview
20.3.6.2. Product Portfolio
20.3.6.3. Sales Footprint
20.3.6.4. Strategy Overview
20.3.7. Illumina
20.3.7.1. Overview
20.3.7.2. Product Portfolio
20.3.7.3. Sales Footprint
20.3.7.4. Strategy Overview
20.3.8. Merck (Sigma Aldrich)
20.3.8.1. Overview
20.3.8.2. Product Portfolio
20.3.8.3. Sales Footprint
20.3.8.4. Strategy Overview
20.3.9. New England Biolabs
20.3.9.1. Overview
20.3.9.2. Product Portfolio
20.3.9.3. Sales Footprint
20.3.9.4. Strategy Overview
20.3.10. Novozymes
20.3.10.1. Overview
20.3.10.2. Product Portfolio
20.3.10.3. Sales Footprint
20.3.10.4. Strategy Overview
21. Assumptions and Acronyms Used
22. Research Methodology